Meeder Advisory Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Buy |
36,885
+2,725
| +8% | +$293K | 0.21% | 73 |
|
|
2025
Q1 | $3.45M | Buy |
34,160
+2,895
| +9% | +$292K | 0.21% | 78 |
|
|
2024
Q4 | $2.79M | Buy |
31,265
+528
| +2% | +$47.2K | 0.17% | 93 |
|
|
2024
Q3 | $2.58M | Sell |
30,737
-1,161
| -4% | -$97.3K | 0.17% | 98 |
|
|
2024
Q2 | $2.46M | Buy |
31,898
+8,566
| +37% | +$660K | 0.17% | 100 |
|
|
2024
Q1 | $1.6M | Buy |
23,332
+745
| +3% | +$51K | 0.16% | 108 |
|
|
2023
Q4 | $1.31M | Buy |
22,587
+387
| +2% | +$22.4K | 0.15% | 117 |
|
|
2023
Q3 | $1.17M | Sell |
22,200
-3,005
| -12% | -$159K | 0.15% | 119 |
|
|
2023
Q2 | $1.36M | Buy |
25,205
+312
| +1% | +$16.9K | 0.15% | 116 |
|
|
2023
Q1 | $1.25M | Buy |
24,893
+816
| +3% | +$40.8K | 0.14% | 124 |
|
|
2022
Q4 | $1.11M | Buy |
+24,077
| New | +$1.11M | 0.14% | 135 |
|